Stay updated on Tislelizumab vs Chemotherapy in Esophageal Cancer Clinical Trial
Sign up to get notified when there's something new on the Tislelizumab vs Chemotherapy in Esophageal Cancer Clinical Trial page.

Latest updates to the Tislelizumab vs Chemotherapy in Esophageal Cancer Clinical Trial page
- Check2 days agoChange DetectedThe page revision tag was updated from v3.6.6 to v3.7.0 to reflect a newer version of the study record.SummaryDifference0.0%

- Check9 days agoChange DetectedA new bibliographic entry was added to the Publications section, citing Moehler et al., 'Concordance Between the PD-L1 Tumor Area Positivity Score and Combined Positive Score for Gastric or Esophageal Cancers Treated With Tislelizumab' (Mod Pathol, 2025).SummaryDifference0.0%

- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedA new funding/identifier entry, '2017 ( U.S. NIH Grant/Contract )', was added to the study IDs, and the site footer revision updated to 'Revision: v3.6.6'.SummaryDifference0.1%

- Check44 days agoChange DetectedThe page revision tag was updated from v3.6.4 to v3.6.5, indicating a new version of the study page.SummaryDifference0.0%

- Check58 days agoChange DetectedThe page revision tag was updated from v3.6.3 to v3.6.4, indicating a minor update to the page; the core study details and content remain unchanged.SummaryDifference0.0%

- Check80 days agoChange DetectedRevision: v3.6.3 appears on the page, replacing the previous Revision: v3.6.0. This indicates a minor update to the page's revision metadata rather than a change to study details or user-facing content.SummaryDifference0.0%

Stay in the know with updates to Tislelizumab vs Chemotherapy in Esophageal Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tislelizumab vs Chemotherapy in Esophageal Cancer Clinical Trial page.